137 related articles for article (PubMed ID: 8006304)
1. Desensitization to trimethoprim/sulfamethoxazole in HIV-infected patients.
Absar N; Daneshvar H; Beall G
J Allergy Clin Immunol; 1994 Jun; 93(6):1001-5. PubMed ID: 8006304
[TBL] [Abstract][Full Text] [Related]
2. Trimethoprim-sulfamethoxazole oral desensitization in hemophiliacs infected with human immunodeficiency virus with a history of hypersensitivity reactions.
Kletzel M; Beck S; Elser J; Shock N; Burks W
Am J Dis Child; 1991 Dec; 145(12):1428-9. PubMed ID: 1688295
[TBL] [Abstract][Full Text] [Related]
3. Rapid oral desensitization to trimethoprim-sulfamethoxazole in infants and children.
Palusci VJ; Kaul A; Lawrence RM; Haines KA; Kwittken PL
Pediatr Infect Dis J; 1996 May; 15(5):456-60. PubMed ID: 8724071
[TBL] [Abstract][Full Text] [Related]
4. Two-day oral desensitization to trimethoprim-sulfamethoxazole in HIV-infected patients.
Nguyen MT; Weiss PJ; Wallace MR
AIDS; 1995 Jun; 9(6):573-5. PubMed ID: 7662195
[TBL] [Abstract][Full Text] [Related]
5. Intermittent trimethoprim-sulfamethoxazole compared with dapsone-pyrimethamine for the simultaneous primary prophylaxis of Pneumocystis pneumonia and toxoplasmosis in patients infected with HIV.
Podzamczer D; Salazar A; Jiménez J; Consiglio E; Santín M; Casanova A; Rufí G; Gudiol F
Ann Intern Med; 1995 May; 122(10):755-61. PubMed ID: 7717598
[TBL] [Abstract][Full Text] [Related]
6. TMP-SMX desensitization.
Posit Aware; 1995; ():7. PubMed ID: 11362574
[TBL] [Abstract][Full Text] [Related]
7. Successful oral desensitization to trimethoprim-sulfamethoxazole in acquired immune deficiency syndrome.
Kalanadhabhatta V; Muppidi D; Sahni H; Robles A; Kramer M
Ann Allergy Asthma Immunol; 1996 Nov; 77(5):394-400. PubMed ID: 8933778
[TBL] [Abstract][Full Text] [Related]
8. Rapid oral desensitization to trimethoprim-sulfamethoxazole (TMP-SMZ): use in prophylaxis for Pneumocystis carinii pneumonia in patients with AIDS who were previously intolerant to TMP-SMZ.
Gluckstein D; Ruskin J
Clin Infect Dis; 1995 Apr; 20(4):849-53. PubMed ID: 7795084
[TBL] [Abstract][Full Text] [Related]
9. Successful desensitization to dapsone for Pneumocystis carinii prophylaxis in an HIV-positive patient.
Cook DE; Kossey JL
Ann Pharmacother; 1998 Dec; 32(12):1302-5. PubMed ID: 9876811
[TBL] [Abstract][Full Text] [Related]
10. Trimethoprim-sulfamethoxazole desensitization in AIDS.
Papakonstantinou G; Füessl H; Hehlmann R
Klin Wochenschr; 1988 Apr; 66(8):351-3. PubMed ID: 3260637
[TBL] [Abstract][Full Text] [Related]
11. A life-threatening adverse reaction during trimethoprim-sulfamethoxazole desensitization in a previously hypersensitive patient infected with human immunodeficiency virus.
Caumes E; Guermonprez G; Winter C; Katlama C; Bricaire F
Clin Infect Dis; 1996 Dec; 23(6):1313-4. PubMed ID: 8953079
[No Abstract] [Full Text] [Related]
12. Trimethoprim-sulfamethoxazole (cotrimoxazole) desensitization in an HIV-infected 5-yr-old girl.
Gómez-Traseira C; Boyano-Martínez T; Escosa-García L; Pedrosa M; Martín-Muñoz F; Quirce S
Pediatr Allergy Immunol; 2015 May; 26(3):287-289. PubMed ID: 25692246
[No Abstract] [Full Text] [Related]
13. Desensitization to co-trimoxazole (trimethoprim-sulphamethoxazole) in HIV-infected patients: is patch testing a useful predictor of reaction?
Gompels MM; Simpson N; Snow M; Spickett G; Ong E
J Infect; 1999 Mar; 38(2):111-5. PubMed ID: 10342651
[TBL] [Abstract][Full Text] [Related]
14. Severe co-trimoxazole reaction in a man with AIDS.
Shepherd J; Shepherd C; Tonozzi C; Boysen E
J Am Board Fam Pract; 1995; 8(2):130-3. PubMed ID: 7778481
[TBL] [Abstract][Full Text] [Related]
15. "Treating through" hypersensitivity to cotrimoxazole in children with HIV infection.
Kreuz W; Güngör T; Lotz C; Funk M; Kornhuber B
Lancet; 1990 Aug; 336(8713):508-9. PubMed ID: 1975015
[No Abstract] [Full Text] [Related]
16. A severe systemic reaction to trimethoprim-sulfamethoxazole in a patient infected with the human immunodeficiency virus.
Martin GJ; Paparello SF; Decker CF
Clin Infect Dis; 1993 Jan; 16(1):175-6. PubMed ID: 8448303
[No Abstract] [Full Text] [Related]
17. Sulfonamide desensitization in solid organ transplant recipients: A protocol-driven approach during the index transplant hospitalization.
Pryor JB; Olyaei AJ; Kirsch D; Strasfeld L
Transpl Infect Dis; 2019 Dec; 21(6):e13191. PubMed ID: 31596538
[TBL] [Abstract][Full Text] [Related]
18. Management of adverse reactions to prophylactic trimethoprim-sulfamethoxazole in patients with human immunodeficiency virus infection.
Belchi-Hernandez J; Espinosa-Parra FJ
Ann Allergy Asthma Immunol; 1996 Apr; 76(4):355-8. PubMed ID: 8612118
[TBL] [Abstract][Full Text] [Related]
19. A randomized, pilot trial comparing full versus escalating dose regimens for the desensitization of AIDS patients allergic to sulfonamides.
Straatmann A; Bahia F; Pedral-Sampaio D; Brites C
Braz J Infect Dis; 2002 Dec; 6(6):276-80. PubMed ID: 12585970
[TBL] [Abstract][Full Text] [Related]
20. A 5-day course of oral desensitization to trimethoprim/sulfamethoxazole (T/S) in patients with human immunodeficiency virus type-1 infection who were previously intolerant to T/S.
Yoshizawa S; Yasuoka A; Kikuchi Y; Honda M; Gatanaga H; Tachikawa N; Hirabayashi Y; Oka S
Ann Allergy Asthma Immunol; 2000 Sep; 85(3):241-4. PubMed ID: 11030281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
